Alzheimer - Phase III Alzheimers Disease Drug Trial Semagacestat

ctSearch Results

Original Query

Alzheimer - Phase III Alzheimers Disease Drug Trial Semagacestat

Search Results

1. alzheimer phase iii alzheimers disease drug trial semagacestat

Preview

• Janssen Alzheimer Immunotherapy is undertaking Phase III development of bapineuzumab, a monoclonal antibody which targets the amyloid plaques and which is being evaluated for slowing the progression of Alzheimers disease


• Lilly halts dosing in Phase III Alzheimer`s disease drug trial of semagacestat


• In the IDENTITY (Interrupting Alzheimer`s dementia by evaluating treatment of amyloid pathology) trial, a Phase III study involving more than 3,000 Alzheimer`s patients, those treated with the drug had more rapid progression and worsening of symptoms compared with those on placebo

---

For more information on each topic click the link(s) above.

---

Contact

Web : http://c-t-search.info
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo

[Return to Medical Expert][Return to Alzheimer Expert]